英国布里斯托大学孵化的AI生物科技初创公司CellVoyant，近日宣布已完成760万英镑的种子轮融资。此轮融资由Octopus Ventures领投，Horizons Ventures、Air Street Capital和Verve Ventures参投。
CellVoyant公司致力于利用人工智能成像技术，帮助干细胞疗法开发商更高效地制造新疗法。干细胞疗法是一种具有巨大潜力的新型疗法，可以用于治疗许多目前无法治愈的疾病。然而，干细胞疗法的研发过程却面临着诸多挑战，其中之一就是如何高效地制造出高质量的新疗法。
CellVoyant的人工智能成像技术可以对干细胞疗法制造过程中的图像进行智能分析，从而实时监测和调整制造过程，提高新疗法的质量和效率。此外，该技术还可以为干细胞疗法的研究提供更深入的理解，推动该领域的研究进展。
CellVoyant公司的创始人兼首席执行官表示，完成此轮融资后，公司将进一步加强其人工智能成像技术的研发，并加速其干细胞疗法研发管线的推进。
随着此轮融资的完成，CellVoyant公司有望在未来的干细胞疗法研发领域发挥重要作用。其人工智能成像技术的应用，将大大推动干细胞疗法的发展，为患者带来更好的治疗选择。
英文翻译：
British AI biotech startup CellVoyant, recently announced the completion of a £7.6 million seed round of financing. This round of financing was led by Octopus Ventures, with participation from Horizons Ventures, Air Street Capital, and Verve Ventures.
CellVoyant is committed to using artificial intelligence imaging technology to help stem cell therapy developers manufacture new therapies more effectively. Stem cell therapy is a novel type of therapy with great potential, which can be used to treat many currently incurable diseases. However, the research and development process of stem cell therapy faces many challenges, one of which is how to efficiently produce high-quality new therapies.
CellVoyant’s artificial intelligence imaging technology can intelligently analyze images during the manufacturing process of stem cell therapies, allowing for real-time monitoring and adjustment of the manufacturing process, thereby improving the quality and efficiency of new therapies. In addition, this technology can provide a deeper understanding of stem cell therapies, promoting research progress in this field.
Following the completion of this round of financing, the company plans to further strengthen the research and development of its artificial intelligence imaging technology and accelerate the advancement of its stem cell therapy research pipeline.
With the completion of this round of financing, CellVoyant is expected to play an important role in the future research and development of stem cell therapies. The application of its artificial intelligence imaging technology will greatly promote the development of stem cell therapies, bringing better treatment options to patients.
【来源】https://sifted.eu/articles/ai-biotech-cellvoyant-raise
Views: 1